We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Nano-Fiber Face Mask Provide Maximum Protection to Children

By HospiMedica International staff writers
Posted on 13 Jul 2020
Nano-filter technology designed for surgical respirators has been resized to fit the smaller faces of children, protecting them against COVID-19. More...


The AirQueen (Los Angeles) AirBon, which has been specially sized for pediatric use, is based on the same technology as that of the Air Queen, a highly advanced nano-fiber surgical respirator that provide in excess of 97% particle filtration, while simultaneously allowing for advanced breathability and comfort. Both Air Queen and AirBon are classified as respirator N95 equivalent, and are designed to protect users from the transfer of microorganism, body fluids, and particulate materials. Each mask is individually wrapped.

The nano-fiber, developed at the Korea Advanced Institute of Science and Technology (KAIST; Daejeon, Republic of Korea), is manufactured via an insulation block electrospinning process that manufactures orthogonal nanofibers with a diameter of 100~500 nm by controlling their alignment. The unidirectional nanofiber structure minimizes air pressure delivery toward the filter, maximizing filtration efficiency. The masks are also water resistant, with no deformation in the nano-membrane structure, even after 20 repeated hand washes.

“As quarantines are being lifted, children are beginning to interact on a more regular basis. Soon schools will reopen creating further sources of exposure to children,” declared AirQueen in a press statement. “Many children are using masks that are sized for adults, which reduces the protection they receive. Furthermore, many children are using cloth masks or 3-ply versions of the masks which are substantially inferior when compared to the protection provided by the AirBon.”

The N95 designation means that the respirator blocks at least 95% of very small particles, exceeding the capabilities of regular surgical face masks.

Related Links:
AirQueen
Korea Advanced Institute of Science and Technology



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Diagnostic Ultrasound System
DC-80A
New
Radial Artery Compression Device
TR Band
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The milli-spinner can shrink blood clots without rupturing them (Photo courtesy of Andrew Brodhead/Stanford)

New Technology More Than Doubles Success Rate for Blood Clot Removal

In cases of ischemic stroke, where a blood clot obstructs oxygen supply to the brain, time is critical. The faster the clot is removed and blood flow restored, the more brain tissue can be saved, improving... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.